Cardiovascular

  • Feline Cardiomyopathy Consortium  
    October 25, 2011
    The major objective of the consortium is to elucidate the genetic mutations that are directly causative and or increase the risk for developing feline heart disease, with the goal of eradicating and or monitoring the mutations within the cat populations via genetic testing and clinical evaluations.
    Dr Haggstrom
    is looking for cats with cardiomyopathy. See the trial page for specific information on eligibility.
  • Study of the Utility of Rivaroxaban or Clopidogrel for prevention of recurrent Arterial Thromboembolism in cats (SUPERCAT)  
    February 3, 2020
    The SUPER-CAT trial compares clopidogrel to rivaroxaban for prevention of cardiogenic thromboembolism in cats that have experienced and recovered from a cardiogenic thromboembolism.
    Dr Brainard is looking for cats with aortic thromboembolism (saddle thrombus).
    See the trial page for specific information on eligibility.


SAID=27